Use of telephone and web interfaces of interactive response technology at clinical investigator sites in clinical trials

被引:0
|
作者
Saarela, Anna-Leena [1 ,2 ]
Walzer, Anja [3 ]
Juppo, Anne Mari [1 ]
机构
[1] Univ Helsinki, Div Pharmaceut Chem & Technol, Fac Pharm, Formulat & Ind Pharm Unit, Helsinki, Finland
[2] Crown CRO Oy, Vaisalantie 4, Espoo 02130, Finland
[3] Bayer AG, Dev, Pharmaceut, Berlin, Germany
关键词
Clinical trials; interactive response technology; interactive voice response; interactive web response; user interface; randomization; SYSTEMS;
D O I
10.1177/1740774519832329
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Interactive response technologies are used in clinical trials to provide services such as automated randomization and medication logistics management. The objective of this article is to investigate the usage of telephone (Interactive Voice Response) and web (Interactive Web Response) interfaces of interactive response technologies at clinical investigator sites in clinical trials, to obtain information about the preferences of interactive response technology end users between the telephone and web interfaces, and to explore the relevance of the telephone interface in this setting. Methods The data consist of an online survey conducted in spring 2016 with clinical investigators, study nurses, and pharmacists in 13 countries. Results Ninety-eight percent of survey respondents preferred the web interface over the telephone interface, the most important reason being superior usability. However, the respondents indicated the usability of interactive response technology interfaces is not optimal, and lack of integration and consistency across systems is common. A vast majority of interactive response technology end users at clinical sites prefer to use the web interface over the telephone interface, but most also feel there would need to be a back-up system. Conclusions Based on the results, it would be beneficial to improve the usability of the interactive response technology interfaces, and to increase consistency across systems from the current level. Support to and training of the users, as well as clarifying the responsibilities between sites and the sponsor should also be a focal point. Study sponsors should explore with interactive response technology service providers how removing the telephone interface would impact future studies, and whether there could be a more efficient means to achieve a reliable back-up to the web interface instead of a dedicated telephone interface.
引用
收藏
页码:297 / 305
页数:9
相关论文
共 50 条
  • [2] OpenClinica SOFTWARE: USE IN INVESTIGATOR INITIATED CLINICAL TRIALS
    Brassington, Kate
    Robman, Luba
    Keller, Peter
    Tindill, Nicole
    Caruso, Emily
    Guymer, Robyn
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 75 - 75
  • [3] The tricky use of placebo in investigator-based clinical trials
    Duracinsky, M.
    Matei, M.
    Taron, C.
    Lubrano, C.
    Lemaire, F.
    Misse, C.
    Chassany, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 26 - 26
  • [4] Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials
    Sedrak, Mina S.
    Sun, Can-Lan
    Hershman, Dawn L.
    Unger, Joseph M.
    Liu, Jennifer
    Dale, William
    Dizon, Don S.
    [J]. JAMA NETWORK OPEN, 2020, 3 (12)
  • [5] Clinical Trials Without Clinical Sites
    Cummings, Steven R.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (05) : 680 - 684
  • [6] Selection of patients for clinical trials: an interactive web-based system
    Fink, E
    Kokku, PK
    Nikiforou, S
    Hall, LO
    Goldgof, DB
    Krischer, JP
    [J]. ARTIFICIAL INTELLIGENCE IN MEDICINE, 2004, 31 (03) : 241 - 254
  • [7] Clinical trials on the web
    Sikorski, RS
    Peters, R
    [J]. NATURE BIOTECHNOLOGY, 1996, 14 (09) : 1170 - 1170
  • [8] Developing an Investigator Site Budget for Clinical Trials
    不详
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (02) : 94 - 97
  • [9] EFFECT OF INVESTIGATOR BIAS ON CLINICAL-TRIALS
    SMITH, EB
    [J]. ARCHIVES OF DERMATOLOGY, 1989, 125 (02) : 216 - 218
  • [10] Innovative Use of mHealth and Clinical Technology for Oncology Clinical Trials in Africa
    Mutebi, Miriam
    Bhatia, Rohini
    Salako, Omolola
    Rubagumya, Fidel
    Grover, Surbhi
    Hammad, Nazik
    [J]. JCO GLOBAL ONCOLOGY, 2020, 6 : 948 - 953